Desley van Zoggel

Impact of metastases on survival 83 CHAPTER 5 Synchronousmetastases (N= 46) History of metastases (N = 42) History of metastases Synchronous metastases 23 9 15 10 3 9 13 6 6 22 8 11 4 3 1 0 0 2 0 0 2 13 2 6 11 1 3 2 1 3 11 2 1 2 0 4 0 0 1 7 5 18 3 1 6 4 4 12 3 2 10 4 3 8 3 1 6 2 0 2 1 1 4 3 0 3 0 1 3 0 0 2 NA NA 2 NA NA 0 NA 1 2 NA 0 1 c Only the definitive treatment for a specific metastasis is listed. If neoadjuvant chemotherapy was administered before metastasectomy, the chemotherapy was not scored as a treatment. d Including metastases in the ovary and abdominal wall. HIPEC, hyperthermic intraperitoneal chemotherapy; NA, not applicable; PCI, peritoneal cancer index; RFA, radio frequency ablation.

RkJQdWJsaXNoZXIy MTk4NDMw